MiR-155, moreover, has been involved in cardiac remodeling, and miR155 deletion or inhibition reduced inflammatory and fibrotic responses in animal models of cardiac fibrosis induced by angiotensin-II (Ang-II) or diabetes (42, 43). This evidence concerns the gene AGT and diabetes mellitus.